{
    "Trade/Device Name(s)": [
        "Verigene\u00ae Respiratory Virus Plus Nucleic Acid Test (RV+)",
        "Verigene\u00ae System"
    ],
    "Submitter Information": "Nanosphere, Inc.",
    "510(k) Number": "K103209",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092566",
        "K101855"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "NSU"
    ],
    "Summary Letter Date": "December 23, 2010",
    "Summary Letter Received Date": "December 27, 2010",
    "Submission Date": "December 28, 2010",
    "Regulation Number(s)": [
        "21CFR866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza A subtype H1",
        "Influenza A subtype H3",
        "2009 H1N1",
        "Influenza B",
        "Respiratory Syncytial Virus (RSV) subtype A",
        "Respiratory Syncytial Virus (RSV) subtype B"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Verigene\u00ae System",
        "Verigene Processor SP",
        "Verigene Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Magnetic bead-based viral RNA extraction",
        "Multiplex RT-PCR",
        "Gold nanoparticle probe-based detection",
        "Hybridization",
        "Automated nucleic acid extraction"
    ],
    "Methodologies": [
        "Multiplex RT-PCR",
        "Hybridization",
        "Molecular diagnostics"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Instrument",
        "Reagent",
        "Cartridge",
        "Consumable",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for the Verigene Respiratory Virus Plus Nucleic Acid Test (RV+) for detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs using the Verigene System.",
    "Indications for Use Summary": "Qualitative multiplex nucleic acid test intended to simultaneously detect and identify Influenza A (including H1, H3, 2009 H1N1), Influenza B, and RSV (subtypes A and B) nucleic acids in nasopharyngeal swab specimens from individuals with signs and symptoms of respiratory tract infection to aid diagnosis, when used in conjunction with other clinical and laboratory findings.",
    "fda_folder": "Microbiology"
}